Skip to content
type1.science
Phase 2Not yet recruitingNCT06227221

Sorafenib in new-onset T1D

Small phase 2 placebo-controlled study testing whether sorafenib can preserve mixed-meal-stimulated C-peptide in adults with new-onset type 1 diabetes.

Primary endpoints

  • Change from baseline in 2-hour mixed-meal C-peptide AUC

Results so far

No results posted yet.